Literature DB >> 22735584

Gain of function in CDKN1C.

Andrea Riccio, Maria Vittoria Cubellis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22735584     DOI： 10.1038/ng.2336

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

Review 1.  Russell-Silver syndrome.

Authors:  Thomas Eggermann
Journal:  Am J Med Genet C Semin Med Genet       Date:  2010-08-15       Impact factor: 3.908

Review 2.  p57(Kip2) and cancer: time for a critical appraisal.

Authors:  Adriana Borriello; Ilaria Caldarelli; Debora Bencivenga; Maria Criscuolo; Valeria Cucciolla; Annunziata Tramontano; Adriana Oliva; Silverio Perrotta; Fulvio Della Ragione
Journal:  Mol Cancer Res       Date:  2011-08-04       Impact factor: 5.852

Review 3.  Mechanism of CRL4(Cdt2), a PCNA-dependent E3 ubiquitin ligase.

Authors:  Courtney G Havens; Johannes C Walter
Journal:  Genes Dev       Date:  2011-08-01       Impact factor: 11.361

4.  Suppression of cell transformation by the cyclin-dependent kinase inhibitor p57KIP2 requires binding to proliferating cell nuclear antigen.

Authors:  H Watanabe; Z Q Pan; N Schreiber-Agus; R A DePinho; J Hurwitz; Y Xiong
Journal:  Proc Natl Acad Sci U S A       Date:  1998-02-17       Impact factor: 11.205

5.  Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome.

Authors:  P Zhang; N J Liégeois; C Wong; M Finegold; H Hou; J C Thompson; A Silverman; J W Harper; R A DePinho; S J Elledge
Journal:  Nature       Date:  1997-05-08       Impact factor: 49.962

6.  Downregulation of the KIP family members p27(KIP1) and p57(KIP2) by SKP2 and the role of methylation in p57(KIP2) inactivation in nonsmall cell lung cancer.

Authors:  Ioannis S Pateras; Kalliopi Apostolopoulou; Marilena Koutsami; Kostas Evangelou; Petros Tsantoulis; Triantafillos Liloglou; Giorgos Nikolaidis; Fragiska Sigala; Christos Kittas; John K Field; Athanassios Kotsinas; Vassilis G Gorgoulis
Journal:  Int J Cancer       Date:  2006-12-01       Impact factor: 7.396

7.  CRL4(Cdt2) E3 ubiquitin ligase monoubiquitinates PCNA to promote translesion DNA synthesis.

Authors:  Kenta Terai; Tarek Abbas; Amir A Jazaeri; Anindya Dutta
Journal:  Mol Cell       Date:  2010-01-15       Impact factor: 17.970

8.  The CRL4Cdt2 ubiquitin ligase targets the degradation of p21Cip1 to control replication licensing.

Authors:  Youngjo Kim; Natalia G Starostina; Edward T Kipreos
Journal:  Genes Dev       Date:  2008-09-15       Impact factor: 11.361

9.  Degradation of p57Kip2 mediated by SCFSkp2-dependent ubiquitylation.

Authors:  Takumi Kamura; Taichi Hara; Shuhei Kotoshiba; Masayoshi Yada; Noriko Ishida; Hiroyuki Imaki; Shigetsugu Hatakeyama; Keiko Nakayama; Keiichi I Nakayama
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-18       Impact factor: 11.205

10.  Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome.

Authors:  Valerie A Arboleda; Hane Lee; Rahul Parnaik; Alice Fleming; Abhik Banerjee; Bruno Ferraz-de-Souza; Emmanuèle C Délot; Imilce A Rodriguez-Fernandez; Debora Braslavsky; Ignacio Bergadá; Esteban C Dell'Angelica; Stanley F Nelson; Julian A Martinez-Agosto; John C Achermann; Eric Vilain
Journal:  Nat Genet       Date:  2012-05-27       Impact factor: 38.330
View more
  6 in total

1.  Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes.

Authors:  Amilcar Cordeiro; Ana Paula Neto; Filipa Carvalho; Carla Ramalho; Sofia Dória
Journal:  J Assist Reprod Genet       Date:  2014-07-02       Impact factor: 3.412

2.  Genome-wide methylation analysis of prostate tissues reveals global methylation patterns of prostate cancer.

Authors:  Jian-Hua Luo; Ying Ding; Rui Chen; George Michalopoulos; Joel Nelson; George Tseng; Yan P Yu
Journal:  Am J Pathol       Date:  2013-04-10       Impact factor: 4.307

3.  CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.

Authors:  Ruiying Zhao; Heng-Yin Yang; Jihyun Shin; Liem Phan; Lekun Fang; Ting-Fang Che; Chun-Hui Su; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2013-02-19       Impact factor: 4.534

4.  Mild Beckwith-Wiedemann and severe long-QT syndrome due to deletion of the imprinting center 2 on chromosome 11p.

Authors:  Fiorella Gurrieri; Marcella Zollino; Antonio Oliva; Vincenzo Pascali; Daniela Orteschi; Roberta Pietrobono; Antonella Camporeale; Monica Coll Vidal; Sara Partemi; Ramon Brugada; Fulvio Bellocci; Giovanni Neri
Journal:  Eur J Hum Genet       Date:  2013-03-20       Impact factor: 4.246

5.  CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.

Authors:  Bo Chen; Ruiying Zhao; Chun-Hui Su; Monica Linan; Chieh Tseng; Liem Phan; Lekuan Fang; Heng-Yin Yang; Huiling Yang; Wenqian Wang; Xiaoyin Xu; Nan Jiang; Shouliang Cai; Feng Jin; Sai-Ching J Yeung; Mong-Hong Lee
Journal:  Cell Cycle       Date:  2012-11-27       Impact factor: 4.534

6.  Variable Expressivity of the Beckwith-Wiedemann Syndrome in Four Pedigrees Segregating Loss-of-Function Variants of CDKN1C.

Authors:  Angela Sparago; Flavia Cerrato; Laura Pignata; Francisco Cammarata-Scalisi; Livia Garavelli; Carmelo Piscopo; Alessandra Vancini; Andrea Riccio
Journal:  Genes (Basel)       Date:  2021-05-09       Impact factor: 4.096
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.